TWO SIGMA ADVISERS, LP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$8,512,788
-67.5%
633,392
-59.9%
0.02%
-67.2%
Q1 2023$26,158,133
-22.3%
1,577,692
-12.9%
0.07%
-28.7%
Q4 2022$33,684,451
+63.7%
1,810,992
+12.9%
0.09%
+56.7%
Q3 2022$20,573,000
+172.4%
1,603,492
+48.8%
0.06%
+185.7%
Q2 2022$7,552,000
-26.2%
1,077,292
-12.7%
0.02%
-22.2%
Q1 2022$10,230,000
+69.6%
1,233,992
+38.5%
0.03%
+80.0%
Q4 2021$6,033,000
+180.2%
891,192
+119.4%
0.02%
+150.0%
Q3 2021$2,153,000
-45.8%
406,192
-41.1%
0.01%
-40.0%
Q2 2021$3,969,000
-4.0%
690,192
-23.0%
0.01%
-9.1%
Q1 2021$4,133,000
+69.9%
896,592
+23.1%
0.01%
+57.1%
Q4 2020$2,433,000
+11.6%
728,392
-0.8%
0.01%
+16.7%
Q3 2020$2,181,000
-56.9%
734,292
-32.9%
0.01%
-60.0%
Q2 2020$5,057,000
+197.6%
1,094,592
+148.1%
0.02%
+114.3%
Q1 2020$1,699,000
-0.9%
441,192
-3.5%
0.01%
+75.0%
Q4 2019$1,714,000
+2420.6%
457,092
+3445.5%
0.00%
Q3 2019$68,000
+257.9%
12,892
+28.9%
0.00%
Q4 2018$19,000
-91.4%
10,000
-82.8%
0.00%
-100.0%
Q3 2018$220,000
-18.5%
58,200
-32.8%
0.00%0.0%
Q2 2018$270,000
+70.9%
86,600
+30.6%
0.00%
Q1 2018$158,000
-48.2%
66,300
-15.1%
0.00%
-100.0%
Q4 2017$305,00078,0920.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders